1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow MSH2 Gene Mutation: new trials by email Literature Review of MSH2 Gene Mutation trials Research Report on MSH2 Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy Nivolumab - Colon Adenoma, Colon Carcinoma | Phase 2 | Terminated | John Hays | 3 | 2018-10-04 | 2024-07-01 |
Colonic Neoplasms (1) · Colorectal Neoplasms, Hereditary Nonpolyposis (1)
Colonic Diseases (1) · Colorectal Neoplasms (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · DNA Repair-Deficiency Disorders (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genetic Diseases, Inborn (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Metabolic Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplastic Syndromes, Hereditary (1)
Nivolumab (1)
John Hays (1)
United States (1)